Metraipolis › archive › dc_0bb5222addf3

A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis — Europe PMC PMID:40776639

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40776639
DOI
10.2174/011570159x366227250716054651
License (as archived)
solo-consultazione
Archived
2026-11-07T05:15:56.719Z
SHA-256 of the archived text
170f3de28cf6c955950625b2d0cdf4170b6058f0fece407d2de9b84391e45e8f
Stable URL of this page
https://metraipolis.com/documento/dc_0bb5222addf3

How to cite

A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis — Europe PMC PMID:40776639 — Europe PMC (en), https://europepmc.org/article/MED/40776639 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bb5222addf3 (Metraipolis archive dc_0bb5222addf3, sha256 170f3de28cf6c955950625b2d0cdf4170b6058f0fece407d2de9b84391e45e8f)
BibTeX
@misc{dc0bb5222addf3,
  title = {A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis — Europe PMC PMID:40776639},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40776639},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bb5222addf3; sha256 170f3de28cf6c955950625b2d0cdf4170b6058f0fece407d2de9b84391e45e8f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40776639. Agents can read the archived copy with the MCP tool read_document.